Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Breath Analysis by Ion Mobility Spectrometry

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2016 by Lung Clinic Hemer
Sponsor:
Information provided by (Responsible Party):
Michael Westhoff MD, Lung Clinic Hemer
ClinicalTrials.gov Identifier:
NCT00632307
First received: February 29, 2008
Last updated: September 6, 2016
Last verified: September 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2020
  Estimated Primary Completion Date: June 2020 (Final data collection date for primary outcome measure)
Publications:
Bunkowski A, Maddula S, Davies AN, Westhoff M, Litterst P, Bödeker B, Baumbach JI. One-year time series of investigations of analytes within human breath using ion mobility spectrometryInt. J. Ion Mobil. Spec. (2010) 13:141-148
Westhoff, M, Litterst P, Maddula S, Bödeker B, Rahman S, Davies AN, Baumbach JI. Differentiation of chronic obstructive pulmonary disease (COPD) including lung cancer from healthy control group by breath analysis using ion mobility spectrometry. Int. J. Ion Mobil. Spec. (2010) 13:131-139
Vautz W. Baumbach JI, Westhoff M, Züchner, K, Carstens ETH, Perl T. Breath sampling control for medical application. Int. J. Ion Mobil. Spec. (2010) 13:41-46